SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-019974
Filing Date
2024-05-02
Accepted
2024-05-02 16:00:33
Documents
48
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20240331.htm   iXBRL 10-Q 700995
2 EX-31.1 crdf-033124exhibit311.htm EX-31.1 10713
3 EX-31.2 crdf-033124exhibit312.htm EX-31.2 10683
4 EX-32.1 crdf-033124exhibit321.htm EX-32.1 6117
5 EX-32.2 crdf-033124exhibit322.htm EX-32.2 6087
  Complete submission text file 0001628280-24-019974.txt   3905295

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20240331.xsd EX-101.SCH 21983
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20240331_cal.xml EX-101.CAL 56420
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20240331_def.xml EX-101.DEF 108864
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20240331_lab.xml EX-101.LAB 329795
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20240331_pre.xml EX-101.PRE 217259
51 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20240331_htm.xml XML 566861
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 24907968
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)